During pregnancy, fetal DNA travels from the placenta to the mother’s blood stream and circulates along with her own DNA. VERACITY is a new generation non-invasive prenatal test that accurately measures the fetal cell-free DNA in the maternal blood to detect the presence of fetal aneuploidies and microdeletions. VERACITY has been validated for both singleton, twin and vanishing twin pregnancies.

The doctor or lab collects a blood sample from the mother’s arm and sends it to our state-of-the-art laboratories for analysis. At the laboratory, cell-free DNA is isolated from the mother’s blood and analyzed using our proprietary, new generation analytic and bioinformatic technology. Results are provided to your doctor in a few working days.



It is a test that a pregnant woman can take to check for genetic conditions of the fetus before birth.


During the first trimester, you will be offered a screening test which includes an ultrasound and a biochemical blood test. In combination with other parameters such as the mother’s age, the risk of specific genetic conditions occurring in the fetus is estimated without actually testing fetal DNA. The accuracy of this screening test is low (80 – 95%).

If the prenatal screening indicates that the fetus has a high risk of having a genetic condition, your doctor will recommend an invasive test such as amniocentesis or chorionic villus sampling. These invasive tests are highly accurate (>99%) but they have approximately 1 in 200 chance of causing a miscarriage.

Now, with VERACITY, you have the option of taking a highly accurate (>99%) and safe non-invasive prenatal test.


>99% detection rate


No risk of fetal miscarriage

Non-invasive test using a simple blood draw from the arm with no risk for the mother and the fetus


Can be done from 10 weeks Results in 4-7 working days


Validated in three multi-center studies using thousands of samples. Used by health professionals around the world.



  • Down syndrome (Trisomy 21)
  • Edwards syndrome (Trisomy 18)
  • Patau syndrome (Trisomy 13)


  • Turner syndrome (Monosomy X)
  • Triple X syndrome (Trisomy X)
  • Klinefelter syndrome (XXY)
  • Jacobs syndrome (XYY)
  • XXYY syndrome


  • DiGeorge syndrome (22q11.2)
  • 1p36 deletion syndrome
  • Smith-Magenis syndrome (17p11.2)
  • Wolf-Hirschhorn syndrome (4p16.3)


VERACITY directly tests fetal DNA, therefore, it provides the highest accuracy (>99%) in the detection of the most common fetal aneuploidies and microdeletions.

VERACITY is safe for your baby as it only requires a simple blood draw from the mother, which is not associated with the risk of miscarriage unlike invasive methods like CVS and amniocentesis.

First Trimester
Prenatal Diagnosis
Type of Test
Screening that measures likelihood of trisomies 21, 18 and 13, and X, Y aneuploidies, and four microdeletions. Screening test that measures likelihood of trisomies 21, 18, and 13. Diagnostic test to determine chromosome abnormalities.
Blood draw from 10th week of pregnancy. Blood draw and ultrasound between 11th and 14th weeks of pregnancy.

CVS: Chorionic villus sampling between 10th and 12th weeks of pregnancy.

Amniocentesis: Sampling of amniotic fluid using a needle through the abdomen between 15th and 20th weeks of pregnancy.

Safe. No risks to mother or child. Safe. No risks to mother or child. About 0.5% risk of fetal loss because of inherent invasiveness of the procedure used to obtain fetal material.
Higher than 99% for trisomy 21, 18 and 13 and several other anomalies. 80-95% for trisomy 21, 18 and 13. Higher than 99% for trisomy 21, 18 and 13 and several other anomalies.


No. All pregnant women of any age or risk category can do the VERACITY test. Although the frequency for such genetic conditions rises with the mother’s age, they can happen in any pregnancy.

Your doctor will inform you about the level of your risk.


One of the advantages of VERACITY is that you can take the test as early as the 10th week of your pregnancy and quickly obtain accurate results!




  • What is NIPT?

    NIPT is a non-invasive prenatal test which analyzes cell-free DNA in the mother’s blood to identify genetic syndromes such as trisomies and sex chromosome aneuploidies in the fetus.

  • What is VERACITY?

    VERACITY is a new generation non-invasive prenatal test that analyses cell-free DNA extracted from the mother’s blood to detect fetal genetic disorders. VERACITY can accurately detect trisomies Down syndrome, Edwards syndrome and Patau syndrome. VERACITY also tests for syndromes caused by sex chromosome aneuploidies and microdeletions as well as, provides the option to know the gender of the baby. VERACITY is a robust reliable non-invasive prenatal test that has been validated for singleton and twin pregnancies, and can also be used in IVF pregnancies.

  • Why is VERACITY important to me?

    Non-invasive prenatal testing is important because it provides a safe and accurate way to test the baby before birth for genetic disorders, the most common of which is Down syndrome. Before the introduction of this revolutionary test, the options to test for Down syndrome were either screening methods like ultrasound combined with other lab testing which have low accuracy (approximately 80-95%) or high accuracy prenatal diagnosis that uses invasive methods [e.g. amniocentesis or chorionic villi sampling (CVS)] which have 0.5% risk for miscarriage. VERACITY is a new generation non-invasive prenatal test that has significantly greater accuracy (>99%) and no risk for miscarriage.

  • What are Down syndrome, Edwards syndrome and Patau syndrome?

    Down syndrome, Edwards syndrome and Patau syndrome are genetic disorders caused by chromosomal trisomies. Down syndrome is caused by an extra copy of chromosome 21 whereas Edwards syndrome and Patau syndrome are caused by an extra copy of chromosome 18 and chromosome 13, respectively. Down syndrome is characterized by intellectual impairment and congenital abnormalities. Down syndrome occurs approximately in 1 in 700 pregnancies but is more frequent in pregnancies in women over 35. Edwards syndrome and Patau syndrome are less common occurring in 1 in 3000 and 1 in 10000 pregnancies, respectively. Edwards and Patau syndromes are characterized by severe congenital abnormalities and rarely survive past the first year of life.

    Ask your doctor about using VERACITY to detect these fetal trisomies.

  • What are sex chromosome aneuploidies?

    Sex chromosome aneuploidies are genetic diseases caused by the presence or absence of a sex chromosome. The 23rd pair of chromosomes determine the sex of an individual. Women have two X chromosomes and men have one X and one Y chromosome. There are four major sex chromosome aneuploidies:

    • Turner syndrome is characterized by the presence of a single X chromosome.
    • Triple X syndrome is characterized by the presence of three X chromosomes.
    • Klinefelter syndrome is characterized by the presence of two X chromosomes and one Y chromosome.
    • Jacob syndrome is characterized by the presence of one X chromosome and two Y chromosomes.

    Ask your doctor about using VERACITY to detect these fetal chromosomal aneuploidies.

  • What are microdeletions?

    Microdeletions are genetic conditions caused by the loss of a part of a chromosome. Microdeletions are characterized by congenital abnormalities and intellectual impairment. The severity of the symptoms varies depending on the size and location of the microdeletion. The most common microdeletion syndrome is DiGeorge syndrome which occurs approximately once in 1000 pregnancies. The prevalence of DiGeorge syndrome increases to 1 in 100 in pregnancies with major structural anomalies such as congenital heart disease.

  • Why should I choose VERACITY?

    VERACITY is a new generation non-invasive prenatal test with unparalleled accuracy. VERACITY can be done for all pregnancies after the 10th week of pregnancy and pregnancies conceived through in-vitro fertilization (IVF).

    The high accuracy of VERACITY has been demonstrated in several clinical validation studies using thousands of samples. VERACITY is fast, providing results to your doctor in a few days upon sample receipt to our laboratory. VERACITY is a safe test for both the mother and the fetus because it is performed using a simple blood draw.

  • How is the VERACITY test done?

    VERACITY requires a blood draw which is perfomed by your doctor or healthcare provider. The blood sample is sent to our laboratory and the results are provided to your doctor in few days. Your doctor or healthcare provider will discuss your VERACITY results and provide counseling.

  • How much does VERACITY cost?

    VERACITY is a new generation targeted non-invasive prenatal test. Its unique state-of-the-art design that confers unparalled accuracy also makes it a highly affordable test for the detection of fetal chromosomal aneuploidies. Please contact your healthcare provider regarding the cost of VERACITY and payment options in your country.

  • I have other questions. Where can I find additional information?

    Please contact your doctor or healthcare provider for additional information.

Other Products

NIPD Genetics - Privacy Policy

General Statement

This Privacy Policy applies only to www.nipd.com and its subdomains (hereafter collectively referred to as “Sites") that link to this policy. NIPD Genetics Sites are owned by NIPD Genetics Public Company Ltd and are operated by NIPD Genetics Public Company Ltd and on occasion by a third-party that is responsible for the technical maintenance of the Sites.

If, you do not agree with this Privacy Policy, please do not access or use any of NIPD Genetics Sites.

NIPD Genetics values your interest in NIPD Genetics, its products and its services. NIPD Genetics takes the protection of your data seriously.

Personal data for purposes of this Privacy Policy, is any information by which you can be individually identified, including, but not limited to, your name, profession, address, e-mail address, and telephone number.

You may contact NIPD Genetics Public Company Ltd at
NIPD Genetics Public Company Ltd
Neas Engomis 31
Engomi, Nicosia
2409, Cyprus

NIPD Genetics Data Protection Officer can be reached at dpo@nipd.com

This Privacy Policy applies only to the Sites as defined above and which are operated by NIPD Genetics. The NIPD Genetics Privacy Policy seeks to inform the users of its Sites of the following:

NIPD Genetics will not use or share your information with anyone, except as described in this Privacy Policy. This Privacy Policy does not apply to any information we might collect by other digital and offline means and or from other digital and offline sources. The use of information collected through our Sites shall be limited to the purposes under this Privacy Policy and our Terms of Use to customers.

This page informs you of our policies regarding the collection, use, and disclosure of personal data when you use our Sites and the choices you have associated with that data.

We use your data to provide and improve the Sites. By using the Sites, you agree to the collection and use of information in accordance with this policy. Unless otherwise defined in this Privacy Policy, terms used in this Privacy Policy have the same meanings as in our Terms and Conditions, accessible from www.nipd.com

Type of personal information NIPD Genetics may collect through its Sites

Information Collection And Use

We collect several different types of information for various purposes to provide and improve our Sites and services to you.

Personal Data

While using NIPD Genetics Sites, you may be asked to provide NIPD Genetics certain personally identifiable information that can be used to contact or identify you ("Personal Information"). Personal Information that might be used to identify you includes, but is not limited to:

If you send us a query via our Contact us form, your email address, the content and any follow up emails are retained indefinitely.

Cookies and Usage Data

Usage Data

We may also collect information how the Sites are accessed and used ("Usage Data"). This Usage Data may include information such as your computer's Internet Protocol address (e.g. IP address), browser type, browser version, the pages of our Sites that you visit, the time and date of your visit, the time spent on those pages, unique device identifiers and other diagnostic data.

Tracking & Cookies Data

We use cookies and similar tracking technologies to track the activity on our Sites and hold certain information.

Cookies are files with small amount of data which may include an anonymous unique identifier. Cookies are sent to your browser from a website and stored on your device. Tracking technologies also used are beacons, tags, and scripts to collect and track information and to improve and analyze our Sites.

You can instruct your browser to refuse all cookies or to indicate when a cookie is being sent. However, if you do not accept cookies, you may not be able to use some portions of our Sites.

Examples of Cookies we use:

Session Cookies. We use Session Cookies to operate our Sites.

Preference Cookies. We use Preference Cookies to remember your preferences and various settings.

Security Cookies. We use Security Cookies for security purposes.

Visitor behavior cookies. To understand how visitors use and navigate the Sites

Keyword cookies. To understand how visitors discover the Sites.

Use of Data

www.nipd.com uses the collected data for various purposes:

Transfer of Data

Your information, including personal data, may be transferred to — and maintained on — computers located outside of your province, country or other governmental jurisdiction where the data protection laws may differ than those from your jurisdiction.

If you are located outside Cyprus and choose to provide information to us, please note that we transfer the data, including personal data, to Cyprus and process it there.

Your consent to this Privacy Policy followed by your submission of such information represents your agreement to that transfer.

www.nipd.com will take all reasonable steps necessary to ensure that your data is treated securely and in accordance with this Privacy Policy and no transfer of your personal data will take place to an organization or a country unless there are adequate controls in place including the security of your data and other personal information.

Disclosure of Data

NIPD Genetics complies with the protection of personal data regulation and will not sale or trade your personal data.

NIPD Genetics may disclose your personal data in the good faith belief that such action is necessary to:

Security of Data

The security of your data is important to us, but remember that no method of transmission over the Internet, or method of electronic storage is 100% secure. While we strive to use commercially acceptable means to protect your Personal Data, we cannot guarantee its absolute security.

Service Providers

We may employ third party companies and individuals to facilitate, maintain or operate our Sites ("Service Providers"), to provide the SItes on our behalf, to perform service-related services or to assist us in analyzing how our Sites is used.

These third parties have access to your Personal Data only to perform these tasks on our behalf and are obligated not to disclose or use it for any other purpose.


We may use third-party Service Providers to monitor and analyze the use of our Sites.

Google Analytics

Google Analytics is a web analytics service offered by Google that tracks and reports website traffic. Google uses the data collected to track and monitor the use of our Service. This data is shared with other Google services. Google may use the collected data to contextualize and personalize the ads of its own advertising network.

You can opt-out of having made your activity on the Service available to Google Analytics by installing the Google Analytics opt-out browser add-on. The add-on prevents the Google Analytics JavaScript (ga.js, analytics.js, and dc.js) from sharing information with Google Analytics about visits activity.

For more information on the privacy practices of Google, please visit the Google Privacy & Terms web page

Access to your personal data, correction, deletion, and Opting Out

You have the right to review, update or delete any of your personal data by sending a request at NIPD Genetics Personal Data Officer pdo@nipd.com

Links to Other Sites

Our Sites may contain links to other sites that are not operated by us. If you click on a third-party link, you will be directed to that third party's site. We strongly advise you to review the Privacy Policy of every site you visit.

We have no control over and assume no responsibility for the content, privacy policies or practices of any third-party sites or services.

Children's Privacy

Our Service does not address anyone under the age of 18 ("Children").

We do not knowingly collect personally identifiable information from anyone under the age of 18. If you are a parent or guardian and you are aware that your Children has provided us with Personal Data, please contact us. If we become aware that we have collected Personal Data from children without verification of parental consent, we take steps to remove that information from our servers.

Changes to This Privacy Policy

We may update our Privacy Policy from time to time. We will notify you of any changes by posting the new Privacy Policy on this page.

We will let you know via email and/or a prominent notice on our Service, prior to the change becoming effective and update the "effective date" at the top of this Privacy Policy.

You are advised to review this Privacy Policy periodically for any changes. Changes to this Privacy Policy are effective when they are posted on this page.

Contact Us

If you have any questions about this Privacy Policy, please contact pdo@nipd.com

Ok got it!